HSA

Hussman Strategic Advisors Portfolio holdings

AUM $462M
1-Year Est. Return 3.97%
This Quarter Est. Return
1 Year Est. Return
+3.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$438M
AUM Growth
+$25.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
312
New
Increased
Reduced
Closed

Top Buys

1
+$8.49M
2
+$4.71M
3
+$4.1M
4
GL icon
Globe Life
GL
+$3.92M
5
EPAM icon
EPAM Systems
EPAM
+$3.71M

Top Sells

1
+$4.92M
2
+$4.65M
3
+$3.84M
4
CNXC icon
Concentrix
CNXC
+$3.51M
5
BG icon
Bunge Global
BG
+$3.21M

Sector Composition

1 Healthcare 22.59%
2 Technology 17.67%
3 Materials 16.79%
4 Financials 11.81%
5 Consumer Staples 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
D icon
201
Dominion Energy
D
$52.2B
$28.3K 0.01%
500
BKH icon
202
Black Hills Corp
BKH
$5.54B
$28.1K 0.01%
500
EIX icon
203
Edison International
EIX
$24B
$25.8K 0.01%
500
VTLE
204
DELISTED
Vital Energy
VTLE
$16.1K ﹤0.01%
1,000
DTE icon
205
DTE Energy
DTE
$28.1B
$13.2K ﹤0.01%
100
HE icon
206
Hawaiian Electric Industries
HE
$2.49B
$10.6K ﹤0.01%
1,000
-210,000
AES icon
207
AES
AES
$10.1B
$10.5K ﹤0.01%
1,000
AEP icon
208
American Electric Power
AEP
$64.1B
$10.4K ﹤0.01%
100
GWRS icon
209
Global Water Resources
GWRS
$254M
$10.2K ﹤0.01%
1,000
AEE icon
210
Ameren
AEE
$28.1B
$9.6K ﹤0.01%
100
AMPH icon
211
Amphastar Pharmaceuticals
AMPH
$1.2B
– –
-31,500
JKS
212
JinkoSolar
JKS
$1.52B
– –
-126,000
KNTK icon
213
Kinetik
KNTK
$2.47B
– –
-42,000
KO icon
214
Coca-Cola
KO
$303B
– –
-21,000
REGN icon
215
Regeneron Pharmaceuticals
REGN
$77B
– –
-2,100
RUN icon
216
Sunrun
RUN
$4.23B
– –
-105,000
SBH icon
217
Sally Beauty Holdings
SBH
$1.52B
– –
-210,000
VITL icon
218
Vital Farms
VITL
$1.31B
– –
-84,000
VLTO icon
219
Veralto
VLTO
$25.5B
– –
-16,800
ABM icon
220
ABM Industries
ABM
$2.72B
– –
-63,000
ACMR icon
221
ACM Research
ACMR
$3.48B
– –
-63,000
ADBE icon
222
Adobe
ADBE
$122B
– –
-2,100
ADM icon
223
Archer Daniels Midland
ADM
$31.3B
– –
-52,500
AGX icon
224
Argan
AGX
$5.32B
– –
-16,800
AMRX icon
225
Amneal Pharmaceuticals
AMRX
$4.22B
– –
-210,000
7 8
9
10 11